We are delighted to share that Dr. Dennis Kappei has been awarded the Singapore Therapeutics Development Review (STDR) pre-pilot grant under the RIE 2025 Human Health & Potential (HHP) Industry Alignment Fund Pre-Positioning (IAF-PP)! He is the lead principal investigator, with Dr. Anand Jeyasekharan serving as a co-investigator for the project titled ‘Give me a break – selectively targeting ALT-positive sarcomas’.